title: Correlations between the ICIQ-SF score and urodynamic findings.
abstract: OBJECTIVE
  The primary aim of this prospective study was to examine the correlations between "The International Consultation on Incontinence Questionnaire-Short Form (ICIQ-SF)" score and urodynamic findings in patients with urge incontinence. In addition, we aimed to observe the alterations of these parameters with antimuscarinic therapy.
  
  
  METHODS
  Between January and December 2005, patients referred to our department with urge incontinence were examined. After taking a detailed clinical history, physical examination, and urinalysis, each patient was asked to complete an ICIQ-SF questionnaire. We carried out subtracted cystometry according to a fixed protocol on all patients. Patients who were defined as detrusor overactivity incontinent were given antimuscarinic therapy for 3 months. Following treatment, filling cystometry and ICIQ-SF scoring were repeated in all patients. All pre- and post-treatment data of 18 male and 42 female patients were transferred to the SPSS 11.0 for Windows program, and statistical analyses were performed.
  
  
  RESULTS
  The patients' ages ranged from 28 to 70 (mean 49.8) years. We found statistically significant differences between the pre- and post-treatment parameters (mean ICIQ-SF score, first sensation, cystometric capacity, maximum detrusor pressure, compliance; P<0.01). We found negative correlation between pre-treatment mean ICIQ-SF score and first sensation (correlation coefficient -0.266, P<0.05) and positive correlation between pre-treatment mean ICIQ-SF score and maximum detrusor pressure (correlation coefficient 0.4, P<0.01).
  
  
  CONCLUSIONS
  ICIQ-SF scoring is a practical and reliable method for baseline and post-treatment evaluation of patients with urge incontinence. Significant correlation exists between ICIQ-SF score and urodynamic parameters.
authors.affiliation: Department of Urology, Gaziantep University, Gaziantep, Turkey.
authors.forename: Ilker
authors.initials: I
authors.lastname: Seckiner
authors.affiliation: Departments of Urology, Zonguldak Karaelmas University, Zonguldak, Turkey.
authors.forename: Cetin
authors.initials: C
authors.lastname: Yesilli
authors.affiliation: Departments of Urology, Zonguldak Karaelmas University, Zonguldak, Turkey.
authors.forename: N Aydin
authors.initials: NA
authors.lastname: Mungan
authors.affiliation: Departments of Urology, Zonguldak Karaelmas University, Zonguldak, Turkey.
authors.forename: Adem
authors.initials: A
authors.lastname: Aykanat
authors.affiliation: Departments of Urology, Zonguldak Karaelmas University, Zonguldak, Turkey.
authors.forename: Bulent
authors.initials: B
authors.lastname: Akduman
mesh_terms: D000328:Adult; D000368:Aged; D001559:Benzhydryl Compounds / Q000627:therapeutic use; D003187:Compliance; D003408:Cresols / Q000627:therapeutic use; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D018727:Muscarinic Antagonists / Q000627:therapeutic use; D010665:Phenylpropanolamine / Q000627:therapeutic use; D011312:Pressure; D011788:Quality of Life; D011795:Surveys and Questionnaires; D000068737:Tolterodine Tartrate; D001743:Urinary Bladder / Q000503:physiopathology; D053202:Urinary Incontinence, Urge / Q000188:drug therapy / Q000503:physiopathology* / Q000523:psychology*; D014563:Urodynamics / Q000502:physiology*
chemical_list: D001559:Benzhydryl Compounds; D003408:Cresols; D018727:Muscarinic Antagonists; D010665:Phenylpropanolamine; D000068737:Tolterodine Tartrate